Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
55.93
-51.52
-92.12%
Share Warrants & Outstandings
Total Reserve
192.63
230.42
-37.79
-16.40%
Shareholder's Funds
197.04
286.35
-89.31
-31.19%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
60.69
-60.69
-100.00%
Secured Loans
0.00
60.69
-60.69
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-1.42
10.42
-11.84
-113.63%
Other Long Term Liabilities
4.85
0.83
4.02
484.34%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
3.43
52.84
-49.41
-93.51%
Current Liabilities
Trade Payables
8.10
76.58
-68.48
-89.42%
Other Current Liabilities
8.45
27.17
-18.72
-68.90%
Short Term Borrowings
0.00
81.40
-81.40
-100.00%
Short Term Provisions
6.59
0.86
5.73
666.28%
Total Current Liabilities
23.15
186.01
-162.86
-87.55%
Total Liabilities
223.61
525.20
-301.59
-57.42%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
38.39
281.29
-242.90
-86.35%
Less: Accumulated Depreciation
26.85
121.17
-94.32
-77.84%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.55
160.13
-148.58
-92.79%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
46.12
58.76
-12.64
-21.51%
Intangible assets under development
0.00
30.64
-30.64
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
27.02
17.66
9.36
53.00%
Long Term Loans & Advances
3.64
5.08
-1.44
-28.35%
Other Non Current Assets
32.28
0.50
31.78
6,356.00%
Total Non-Current Assets
128.52
272.77
-144.25
-52.88%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.63
93.77
-80.14
-85.46%
Sundry Debtors
24.36
92.28
-67.92
-73.60%
Cash and Bank
53.11
37.00
16.11
43.54%
Other Current Assets
1.97
3.05
-1.08
-35.41%
Short Term Loans and Advances
2.01
26.33
-24.32
-92.37%
Total Current Assets
95.09
252.43
-157.34
-62.33%
Net Current Assets (Including Current Investments)
71.94
66.42
5.52
8.31%
Total Current Assets Excluding Current Investments
95.09
252.43
-157.34
-62.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
223.61
525.20
-301.59
-57.42%
Contingent Liabilities
17.20
10.10
7.10
70.30%
Total Debt
0.00
103.88
-103.88
-100.00%
Book Value per share (adjusted)
446.47
53.07
393.40
741.29%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -100.00% vs 0.00% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.85 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.78% vs 50.50% in Mar 2025
Annual - Fixed Assets
Fixed Assets 57.66 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.20% vs 366.84% in Mar 2025
Annual - Investments
Investments 27.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 31.42% vs 22.45% in Mar 2025
Annual - Current Assets
Current Assets 95.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 68.21% vs -48.48% in Mar 2025
